Harmony Biosciences Holdings, Inc. (HRMY)
38.51
+0.36
(+0.94%)
USD |
NASDAQ |
Aug 24, 16:00
38.51
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Debt to Equity Ratio : 0.2211 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2211 |
| March 31, 2026 | 0.2269 |
| December 31, 2025 | 0.2701 |
| September 30, 2025 | 0.2719 |
| June 30, 2025 | 0.2705 |
| March 31, 2025 | 0.2873 |
| December 31, 2024 | 0.3537 |
| September 30, 2024 | 0.3779 |
| June 30, 2024 | 0.4071 |
| March 31, 2024 | 0.4226 |
| December 31, 2023 | 0.4199 |
| September 30, 2023 | 0.4149 |
| June 30, 2023 | 0.3993 |
| March 31, 2023 | 0.4383 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.4782 |
| September 30, 2022 | 0.5616 |
| June 30, 2022 | 0.778 |
| March 31, 2022 | 0.8946 |
| December 31, 2021 | 1.041 |
| September 30, 2021 | 1.264 |
| June 30, 2021 | 1.546 |
| March 31, 2021 | 1.807 |
| December 31, 2020 | 1.999 |
| September 30, 2020 | 2.040 |
| June 30, 2020 | -1.296 |
| March 31, 2020 | -1.302 |
| December 31, 2019 | -1.204 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Liquidia Corp. | 0.9374 |
| Repligen Corp. | 0.3271 |
| Johnson & Johnson | 0.5771 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| ANI Pharmaceuticals, Inc. | 1.022 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.373B |
| Total Liabilities (Quarterly) | 373.84M |
| Shareholders Equity (Quarterly) | 999.24M |
| Current Ratio | 3.479 |
| Net Debt Paydown Yield | -0.13% |